Manulife (Manufacturers Life Insurance)
SPRY icon

Manulife (Manufacturers Life Insurance)’s ARS Pharmaceuticals SPRY Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Sell
16,637
-15,421
-48% -$148K ﹤0.01% 2563
2025
Q4 		$373K Sell
32,058
-415
-1% -$4.04K ﹤0.01% 2288
2025
Q3 		$326K Sell
32,473
-1,547
-5% -$22.2K ﹤0.01% 2358
2025
Q2 		$594K Buy
34,020
+2,469
+8% +$35.6K ﹤0.01% 2089
2025
Q1 		$397K Buy
31,551
+12,025
+62% +$145K ﹤0.01% 2246
2024
Q4 		$206K Sell
19,526
-27,328
-58% -$383K ﹤0.01% 2612
2024
Q3 		$679K Buy
46,854
+25,658
+121% +$305K ﹤0.01% 2120
2024
Q2 		$180K Buy
+21,196
New +$188K ﹤0.01% 2641
2021
Q4 		– Sell
-13,766
Closed -$137K – 3172
2021
Q3 		$137K Buy
13,766
+6,258
+83% +$154K ﹤0.01% 3077
2021
Q2 		$232K Buy
7,508
+490
+7% +$15.7K ﹤0.01% 3002
2021
Q1 		$306K Buy
+7,018
New +$332K ﹤0.01% 2612

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SPRY Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its ARS Pharmaceuticals (SPRY) stake by 48% in Q1 2026, selling an estimated $148K and leaving 16,637 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

Manulife (Manufacturers Life Insurance) first reported a position in SPRY in Q1 2021 and has held it in 11 quarters since. The position peaked at $679K in Q3 2024. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 16,637 shares of ARS Pharmaceuticals worth $134K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 15,421 ARS Pharmaceuticals shares in Q1 2026, an estimated $148K.
  • ARS Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2563 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in ARS Pharmaceuticals in Q1 2021 and has held it in 11 quarters since.
  • Manulife (Manufacturers Life Insurance)'s ARS Pharmaceuticals position peaked at $679K in Q3 2024.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.